Newer Concepts of Atopic Dermatitis

Archives of Dermatology

Volumn 113, Issue 5, 1977, Pages 663-670

  Hanifin, Jon M ^a   Lobitz, Walter C ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOPIC DERMATITIS; DIAGNOSIS; ETIOLOGY; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ANTIBODY FORMATION; ASTHMA; CHEMOTAXIS; CYCLIC AMP; DERMATITIS, ATOPIC; DINITROCHLOROBENZENE; HISTAMINE; HISTAMINE RELEASE; HUMAN; IMMUNITY, CELLULAR; IMMUNOGLOBULIN E; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 0017713909     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1977.01640050123023     Document Type: Article

References (105)

1. Mihm MC Jr, Soter NA, Dvorak HF, et al: The structure of normal skin and the morphology of atopic eczema. J Invest Dermatol 67: 305–312, 1976.
2. Arthur RP, Shelley WB: The nature of itching in dermatitic skin. Ann Intern Med 49: 900–908, 1958.
3. Eyster WH Jr, Roth GM, Kierland RR: Studies on the peripheral vascular physiology of patients with atopic dermatitis. J Invest Dermatol 18: 37–46, 1952.
4. Lobitz WC Jr, Campbell CJ: Physiologic studies in atopic dermatitis (disseminated neurodermatitis): I. The local cutaneous response to intradermally injected acetyl choline and epinephrine. Arch Dermatol 67: 575–589, 1953.
5. Szentivanyi A: The beta adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy Clin Immunol 42: 203–232, 1968.
6. Huntley CC, Lyerly A: Gamma globulin determinations in allergic children. Am J Dis Child 106: 55–64, 1963.
7. Buckley RH, Dees SC, O'Fallon W: Serum immunoglobulin levels in normal children and in uncomplicated childhood allergy. Pediatrics 41: 600–611, 1968.
8. Collins-Williams C, Tkachyk SJ, Toft B, et al: Quantitative immunoglobulins in children with intractable asthma. Ann Allergy 25: 177–182, 1967.
9. Kaufman HS, Hobbs JR: Immunoglobulin deficiencies in an atopic population. Lancet 2: 1061–1063, 1970.
10. Taylor B, Norman AP, Orgel HA, et al: Transient IgA-deficiency and pathogenesis of infantile atopy. Lancet 2: 111–113, 1973.
11. Ohman S, Johansson SGO: Immunoglobulins in atopic dermatitis. Acta Derm Venereol 54: 193–202, 1974.
12. Rajka G: Prurigo Besnier (atopic dermatitis) with special reference to the role of allergic factors: II. The evaluation of the results of skin reactions. Acta Derm Venereol 41: 1–39, 1961.
13. Stone SP, Muller SA, Gleich GJ: IgE levels in atopic dermatitis. Arch Dermatol 108: 806–811, 1973.
14. Peterson RDA, Page AR, Good RA: Wheal and erythema allergy in patients with agammaglobulinemia. J Allergy Clin Immunol 33: 406–411, 1962.
15. Engman MF, Weiss RS, Engman MF Jr: Eczema and environment. Med Clin North Am 20: 651–663, 1936.
16. Ishizaka K, Ishizaka T, Hornbrook MM: Identification of gamma E antibodies as a carrier of reaginic activity. J Immunol 99: 1187–1198, 1967.
17. Johansson SGO: Raised levels of a new immunoglobulin class (IgND) in asthma. Lancet 2: 951–953, 1967.
18. Berg T, Johansson SGO: IgE concentrations in children with atopic diseases. Int Arch Allergy Appl Immunol 36: 219–232, 1969.
19. Bennich H, Johansson SGO: Structure and function of human immunoglobulin E. Adv Immunol 13: 1–55, 1971.
20. Berglund G, Finnstrom O, Johansson SGO, et al: Wiskott-Aldrich syndrome: A study of six cases with determination of the immunoglobulins A, D, G, M and ND. Acta Paediatr Scand 57: 89–97, 1968.
21. Juhlin L, Johansson SGO, Bennich H, et al: Immunoglobulin E in dermatoses: Levels in atopic dermatitis and urticaria. Arch Dermatol 100: 12–16, 1969.
22. Jones HE, Inouye JC, McGerity JL, et al: Atopic disease and serum immunoglobulin-E. Br J Dermatol 92: 17–25, 1975.
23. Ogawa M, Berger PA, McIntyre OR, et al: IgE in atopic dermatitis. Arch Dermatol 103: 575–580, 1971.
24. Gurevitch AW, Heiner DC, Reisner R: IgE in atopic dermatitis and other common dermatoses. Arch Dermatol 107: 712–715, 1973.
25. Johansson SGO, Juhlin L: Immunoglobulin E in healed atopic dermatitis and after treatment with the corticosteroids and azathioprine. Br J Dermatol 82: 10–13, 1970.
26. Arbesman CE, Wypych JI, Reisman RE, et al: IgE levels in sera of patients with pemphigus or bullous pemphigoid. Arch Dermatol 110: 378–381, 1974.
27. Gajl-Peczalaka KJ, Ballow M, Hansen JA, et al: IgE-bearing lymphocytes and atopy in a patient with x-linked infantile agammaglobulinemia. Lancet 1:1254, 1973.
28. Huggins KG, Brostoff J: Local production of specific IgE antibodies in allergic rhinitis patients with negative skin tests. Lancet 2: 148–150, 1975.
29. Jansen CT, Haapalahti J, Hopsu-Havu VK: Immunoglobulin E in the human atopic skin. Arch Dermatol Forsch 246: 299–302, 1973.
30. Currie JM, Wright RC, Miller OW: The frequency of warts in atopic patients. Cutis 8: 244–245, 1971.
31. Hanifin JM, Ray LF, Lobitz WC Jr: Immunologic reactivity in dermatophytosis. Br J Dermatol 90: 1–8, 1974.
32. Malten KE: The occurrence of hybrids between contact allergic eczema and atopic dermatitis (and vice versa) and their significance. Dermatologica 136: 404–406, 1968.
33. Epstein S, Mohigern AH: Incidence of contact sensitivity in contact dermatitis. Arch Dermatol 90: 284–288, 1964.
34. Epstein S: Neomycin sensitivity and atopy. Dermatologica 130: 280–286, 1965.
35. Jillson OF, Corwen WL, Alexander BR: Problems of contact dermatitis in the atopic individual. Ann Allergy 17: 215–223, 1959.
36. Rostenberg A Jr, Sulzberger MB: Some results of patch tests. Arch Dermatol 35: 433–454, 1937.
37. Cronin E, Bandmann HJ, Calnan CD, et al: Contact dermatitis in the atopic. Acta Derm Venereol 50: 183–187, 1970.
38. Palacios J, Fuller EW, Blaylock WK: Immunological capabilities of patients with atopic dermatitis. J Invest Dermatol 47: 484–490, 1966.
39. Jones HE, Lewis C, McMarlin SL: Allergic contact sensitivity in atopic dermatitis. Arch Dermatol 107: 217–222, 1973.
40. Lobitz WC Jr, Honeyman JF, Winkler MW: Suppressed cell-mediated immunity in two adults with atopic dermatitis. Br J Dermatol 86: 317–328, 1972.
41. Cormane RH, Hamerlinck F, Husz S: B and T lymphocytes in certain varieties of dermatitis. Ann NY Acad Sci 254: 592–599, 1975.
42. Papamichail M, Holborow EJ, Keith HI, et al: Subpopulations of human peripheral blood lymphocytes distinguished by combined rosette formation and membrane immunofluorescence. Lancet 2: 64–66, 1972.
43. Gottlieb BR, Hanifin JM: Circulating T-cell deficiency in atopic dermatitis. Clin Res 22:159A, 1974.
44. Luckasen JR, Sabad A, Goltz RW, et al: T and B lymphocytes in atopic dermatitis. Arch Dermatol 110: 375–378, 1974.
45. McGeady SJ, Buckley RH: Depression of cell-mediated immunity in atopic eczema. J Allergy Clin Immunol 56: 393–406, 1975.
46. Hanifin JM, Gottlieb BR: IgE inhibits T-cell rosette formation. Clin Res 22:328A, 1974.
47. Rogge JL, Hanifin JM: Immunodeficiencies in severe atopic dermatitis. Arch Dermatol 112: 1391–1396, 1976.
48. Hanifin JM, Bauman R, Rogge JL: Chemotaxis inhibition by plasma from patients with atopic dermatitis. Clin Res 25:198A, 1977.
49. Dahl B, Thestrup-Pedersen K, Ellegaard J, et al: Lymphocyte transformation, IgE and T-cells in eczema vaccinatum treated with transfer factor. Acta Dermatol Venereol 55: 187–190, 1975.
50. Schoepf E, Boehringer D: IgE in cell-mediated immunity in atopic dermatitis. J Dermatol 1: 133–144, 1974.
51. Grove DI, Reid JG, Forbes IJ: Humoral and cellular immunity in atopic eczema. Br J Dermatol 92: 611–618, 1975.
52. Hashem N, Hirschorn K, Sedlis E, et al: Infantile eczema: Evidence of auto-immunity to human skin. Lancet 2: 269–270, 1963.
53. Pass F, Larsen WG, Lobitz WC Jr: Cultured lymphocytes of atopic patients. Ann Allergy 24: 426–429, 1966.
54. Fjelde A, Kopecka B: Effect of autologous skin extract and phytohemagglutinin on blood leukocytes of atopic dermatitis patients. Dermatologica 134: 95–100, 1967.
55. Uehara M, Ofuji S: The leukocyte migration test in atopic dermatitis. Acta Dermatol Venereol 54: 279–281, 1974.
56. Rostenberg A Jr, Solomon LM: Infantile eczema in systemic disease. Arch Dermatol 98: 41–46, 1968.
57. Aldrich RA, Steinberg AG, Campbell DC: Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. Pediatrics 13: 133–139, 1954.
58. Reed WB, Epstein WL, Boder E, et al: Cutaneous manifestations of ataxia-telangiectasia. JAMA 195: 746–753, 1966.
59. Buckley RH, Ray BB, Belmaker EZ: Extreme hyperimmunoglobulinemia-E and undue susceptibility to infection. Pediatrics 49: 59–70, 1972.
60. Hill HR, Quie PG: Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet 1: 183–187, 1974.
61. Snyderman R, Buckley RH: Defects of monocyte chemotaxis in patients with hyperimmunoglobulinemia-E and undue susceptibility to infection. Clin Res 23:25A, 1975.
62. Jones HE, Artis WM: Histamine inhibition of human lymphocyte transformation. Clin Res 23:452A, 1975.
63. Kikkawa Y, Kamimura K, Hamagaima T, et al: Thymic alymphoplasia with hyper-IgE-globulinemia. Pediatrics 51: 690–696, 1973.
64. Polmar SH, Waldmann TA, Terry WD: IgE in immunodeficiency. Am J Pathol 69: 499–512, 1972.
65. Buckley RH, Fiscus SA: Serum-IgD and IgE concentrations in immunodeficiency diseases. J Clin Invest 55: 257–265, 1975.
66. Schwartz D, Buckley RH: Serum IgE concentrations and skin reactivity to anti-IgE antibody in IgA-deficient patients. N Engl J Med 284: 513–571, 1971.
67. Schiff RI, Buckley RH, Gilbertsen RB, et al: Membrane receptors and in vitro responsiveness of lymphocytes in human immunodeficiency. J Immunol 112: 376–386, 1974.
68. Epstein LB, Ammann AJ: Evaluation of T lymphocyte effector function in immunodeficiency diseases: Abnormality in mitogen-stimulated interferon in patients with selective IgA deficiency. J Immunol 112: 617–626, 1974.
69. Tada T, Okumura K, Taniguchi M: Cellular and humoral controls of reagenic antibody synthesis in the rat, in Goodfriend L, Sehon AH, Orange RP (eds): Mechanisms in Allergy. New York, Marcel Dekker, 1973, pp 43–61.
70. Smith SB: Pathology, ed 6, Anderson WAD (ed). St Louis, CV Mosby, 1972, p 1387.
71. Pantelouris EM: Absence of thymus in a mouse mutant. Nature 217: 370–371, 1968.
72. Scheid M, Boyse EA, Carswell EA, et al: Serologically demonstrable alloantigens of mouse epidermal cells. J Exp Med 135: 938–955, 1972.
73. Williams DH: Skin temperature reaction to histamine in atopic dermatitis (disseminated neurodermatitis). J Invest Dermatol 1: 119–129, 1938.
74. Kalz F, Fekete Z: Studies on the mechanism of the white response and of the delayed blanch phenomenon in atopic subjects by means of coomassie blue. J Invest Dermatol 35: 135–140, 1960.
75. Juhlin L: Vascular skin reactions in atopic dermatitis. Acta Dermatol Venereol 42: 218–229, 1962.
76. Bystryn JC, Freedman RI, Hyman C: Clearance of iodoantipyrene from methocholine blanched skin in atopics. Arch Dermatol 100: 165–168, 1969.
77. Ramsay C: Vascular changes accompanying white dermographism and delayed blanch in atopic dermatitis. Br J Dermatol 81: 37–43, 1969.
78. Warndorff JA: The response of the sweat glands to acetylcholine in atopic subjects. Br J Dermatol 83: 306–309, 1970.
79. Davis MJ, Lawler JC: Observations on the delayed blanch phenomenon in atopic subjects. J Invest Dermatol 30: 127–132, 1958.
80. Hemels HG: The affect of propranolol on the acetylcholine-induced sweat gland response in atopic and in non-atopic subjects. Br J Dermatol 83: 312–315, 1970.
81. Weber RG, Roth GM, Kierland RR: Further contributions to the vascular physiology of atopic dermatitis. J Invest Dermatol 24: 19–30, 1955.
82. Johnson LA, Winkelmann RK: Cutaneous vascular reactivity in atopic children. Arch Dermatol 92: 621–624, 1965.
83. Juhlin L: Skin reactions to iontophoretically administered epinephrine and norepinephrine in atopic dermatitis. J Invest Dermatol 37: 201–205, 1961.
84. Bullough WS: The control of mitotic activity in adult mammalian tissues. Biol Rev 37: 307–342, 1962.
85. Voorhees JJ, Duell EA, Kelsey WH: Dibutyryl cyclic AMP inhibition of epidermal cell division. Arch Dermatol 105: 384–386, 1972.
86. Carr RH, Russe WW, Reed CE: Failure of catecholamines to inhibit epidermal mitosis in vitro. J Allergy Clin Immunol 55: 255–262, 1973.
87. Reed CE, Busse WW, Lee TP: Adrenergic mechanisms and the adenyl cyclase system in atopic dermatitis. J Invest Dermatol 67: 333–338, 1976.
88. Mier PD, Urselmann E: The adenylcyclase of skin: II. Adenylcyclase levels in atopic dermatitis. Br J Dermatol 83: 364–366, 1970.
89. Holla SWJ, Hollman EPMJ, Mier PD, et al: Adenosine 3′, 5′-cyclic monophosphate phosphodiesterase in skin: II. Levels in atopic dermatitis. Br J Dermatol 86: 147–149, 1972.
90. Mier PD, v/d Hurk J, Holla SWJ, et al: Cyclic 3′, 5′ adenosine monophosphate-dependent protein kinase of skin: 2 Levels in atopic dermatitis and psoriasis. Br J Dermatol 87: 577–579, 1972.
91. Cotton DWK, Van Rossum E: Hexokinase, glucose-6-phosphate dehydrogenase and malate dehydrogenase in the isolated sweat glands of normal and atopic subjects. Br J Dermatol 89: 459–465, 1973.
92. Logsden PJ, Middleton E Jr, Coffey RG: Stimulation of leukocyte adenylcyclase by hydrocortisone and isoproterenol in asthmatic and non-asthmatic subjects. J Allergy Clin Immunol 50: 45–56, 1972.
93. Parker CW, Smith JW: Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma: I. Leukocyte responsiveness to beta adrenergic agents. J Clin Invest 52: 48–59, 1973.
94. Parker CW, Eisen AZ: Altered cyclic-AMP metabolism in atopic eczema. Clin Res 20:418, 1972.
95. Lee TP, Storms W, Busse W, et al: A study of atopic epidermis: Adenylcyclase system and mitosis. J Allergy Clin Immunol 53:99, 1974.
96. Lichtenstein LM, Margolis S: Histamine release in vitro: Inhibition by catecholamines and methylxanthines. Science 161: 902–903, 1968.
97. Assem ISK, Schild HO: Inhibition by sympathomimetic amines of histamine release induced by antigen in passively sensitized human lung. Nature 224: 1028–1029, 1969.
98. Orange RP, Laliner MA, Austen KF: The immunological release of histamine and slow reacting substance of anaphylaxin from human lung, in Austen KF, Becker LL (eds): Biochemistry of the Acute Allergic Reactions. Philadelphia, FA Davis Company, 1971, pp 189–204.
99. Kaliner MA, Orange RP, Koopman WJ, et al: Pharmacologic enhancement of the IgE-mediated release of histamine and slow reacting substance of anaphylaxis in the rat, in Lepow IH, Ward PA (eds): Inflammation Mechanisms and Control. New York, Academic Press, 1972, pp 139–150.
100. Ishizaka T, Ishizaka K: IgE molecules and their receptor sites on basophils, in Goodfriend L, Sehon AH, Orange RP (eds): Mechanisms in Allergy. New York, Marcel Dekker, 1973, pp 221–234.
101. Henney CS, Bourne HR, Lichtenstein LM: The role of cyclic 3′, 5′ adenosine monophosphate in the specific cytolytic activity of lymphocytes. J Immunol 108: 1526–1534, 1972.
102. Melmon KL, Bourne HR, Weinstein Y, et al: Hemolytic plaque formation by leukocytes in vitro. J Clin Invest 53: 13–21, 1974.
103. Gillette RW, McKenzie GO, Swanson MH: Modification of the lymphocyte response to mitogens by cyclic-AMP and GMP. J Reticuloendothel Soc 16: 289–299, 1974.
104. Glasgow A, Polgar P, Saporoschetz I, et al: Phytohemagglutinin stimulation of human lymphocytes: Failure to detect an early increase in cyclic-AMP concentration. Clin Immunol Immunopathol 3: 353–362, 1975.
105. Rivkin I, Rosenblatt J, Becker EL: The role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophils. J Immunol 115: 1126–1134, 1975.